References
- Elsiddig KE, Khalil EA, Elhag IA, et al. Granulomatous mammary disease: ten year’s experience with fine needle aspiration cytology. Int J Tuberc Lung Dis. 2003;7(4):365–369.
- Bani-Hani KE, Yaghan RJ, Matalka II, et al. Idiopathic granulomatous mastitis: time to avoid unnecessary mastectomies. Breast J. 2004;10(4):318–322. doi:10.1111/j.1075-122X.2004.21336.x.
- Martinez-Ramos D, Simon-Monterde L, Suelves-Piqueres C, et al. Idiopathic granulomatous mastitis: a systematic review of 3060 patients. Breast J. 2019;25(6):1245–1250. doi:10.1111/tbj.13446.
- Omranipour R, Mohammadi SF, Samimi P. Idiopathic granulomatous lobular mastitis – report of 43 cases from Iran. Introducing a preliminary clinical practice guideline. Breast Care. 2013;8(6):439–443. doi:10.1159/000357320.
- Cserni G, Szajki K. Granulomatous lobular mastitis following drug-induced galactorrhea and blunt trauma. Breast J. 1999;5(6):398–403. doi:10.1046/j.1524-4741.1999.97040.x.
- Saydam M, Yilmaz KB, Sahin M, et al. New findings on autoimmune etiology of idiopathic granulomatous mastitis: serum IL-17, IL-22 and IL-23 levels of patients. J Invest Surg. 2021;34(9):993–997. doi:1080/08941939.2020.1725190.
- Eyerich K, Dimartino V, Cavani A. IL-17 and IL-22 in immunity: driving protection and pathology. Eur J Immunol. 2017;47(4):607–614. doi:10.1002/eji.201646723.
- Kuwabara T, Ishikawa F, Kondo M, Kakiuchi T. The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm. 2017;2017:1–11. doi:10.1155/2017/3908061.
- Benson JR, Dumitru D. Idiopathic granulomatous mastitis: presentation, investigation and management. Future Oncol. 2016;12(11):1381–1394. doi:10.2217/fon-2015-0038.
- First in the world regulatory approval of Novartis’ Cosentyx(TM) in Japan for both psoriasis and psoriatic arthritis. Novartis AG. 2014. 12–26. Available at: https://www.novartis.com.cn/xin-wen-zhong-xin/xin-wen-fa-bu/Cosentyx-in-Japan. Retrieved 2015-03-12.